Amazon is planning to develop a standalone application for viewing sports in the US as it continues to push toward investing in Prime Video. If released, the new app would highlight the tech giant’s sports content, which is currently included in its main Prime Video platform.
Recently, Amazon CEO Andy Jassy said that live sports are a unique asset in which the entity would continue investing.
Currently, the firm’s live sports offerings include exclusive rights to the NFL’s Thursday Night Football. In addition, it comes with some Premier League soccer matches and Yankees baseball games. Also, Amazon invested in other sports content to complement the live games. Lately, it launched original sports talk shows on Prime Video and its ad-supported streaming service, Freevee.
Analysts believe that the company’s plans to develop a standalone sports app suggest that it is exploring new strategies. Besides, the entity is assumed to utilize its live sports investments in additional revenue streams. Hence, experts anticipate that Amazon will charge a separate subscription fee for sports content using the new application.
This latest development comes as the company has been reviewing parts of its unprofitable departments, eliminating several roles.
AWS unveiled gene sequencing for Amazon Omics
Furthermore, Amazon Web Services launched general availability for Amazon Omics. This helps researchers store and analyze data such as the sequence of DNA, RNA, and proteins. Besides, it provides customers with underlying infrastructure that utilizes vast amounts of data to create new scientific discoveries.
In the third quarter, AWS generated a substantial amount of Amazon’s revenue, creating $20.50 billion.
The cloud-computing business has expanded into health care and is anticipated to hit $2.15 billion by 2030.
Analysts believe that Amazon is following in the footsteps of its major tech firm rivals, which developed similar tools in the past. For instance, Microsoft’s cloud-computing platform Azure launched “Microsoft Genomics” in 2018. It aims to help researchers to analyze data generated by genomic technologies.
